HomeCompareZHYBF vs ORCC

ZHYBF vs ORCC: Dividend Comparison 2026

ZHYBF yields 99.01% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZHYBF wins by $3.72M in total portfolio value
10 years
ZHYBF
ZHYBF
● Live price
99.01%
Share price
$2.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.74M
Annual income
$1,252,449.65
Full ZHYBF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ZHYBF vs ORCC

📍 ZHYBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZHYBFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZHYBF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZHYBF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZHYBF
Annual income on $10K today (after 15% tax)
$8,415.84/yr
After 10yr DRIP, annual income (after tax)
$1,064,582.20/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ZHYBF beats the other by $1,064,581.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZHYBF + ORCC for your $10,000?

ZHYBF: 50%ORCC: 50%
100% ORCC50/50100% ZHYBF
Portfolio after 10yr
$1.88M
Annual income
$626,225.34/yr
Blended yield
33.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ZHYBF
No analyst data
Altman Z
5.7
Piotroski
7/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZHYBF buys
0
ORCC buys
0
No recent congressional trades found for ZHYBF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZHYBFORCC
Forward yield99.01%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$3.74M$21.4K
Annual income after 10y$1,252,449.65$1.04
Total dividends collected$3.34M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ZHYBF vs ORCC ($10,000, DRIP)

YearZHYBF PortfolioZHYBF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$20,601$9,900.99$11,190$489.61+$9.4KZHYBF
2$41,106$19,062.64$12,229$256.01+$28.9KZHYBF
3$79,531$35,547.83$13,216$130.74+$66.3KZHYBF
4$149,376$64,278.14$14,207$66.02+$135.2KZHYBF
5$272,663$112,830.11$15,234$33.17+$257.4KZHYBF
6$484,229$192,479.92$16,317$16.62+$467.9KZHYBF
7$837,593$319,467.53$17,468$8.32+$820.1KZHYBF
8$1,412,670$516,446.07$18,695$4.16+$1.39MZHYBF
9$2,325,603$814,046.39$20,006$2.08+$2.31MZHYBF
10$3,740,845$1,252,449.65$21,407$1.04+$3.72MZHYBF

ZHYBF vs ORCC: Complete Analysis 2026

ZHYBFStock

Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company's products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life's NA candies, and seedlings of Acer Truncatum. In addition, it offers demyelination diagnostic kit and nervonic acid supplement. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited is based in Wanchai, Hong Kong.

Full ZHYBF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ZHYBF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZHYBF vs SCHDZHYBF vs JEPIZHYBF vs OZHYBF vs KOZHYBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.